Search Results 51-60 of 17200 for Mycosis
To evaluate the use of SGX301, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides). A ...
... mycosis fungoides: A retrospective validation study. J Am Acad Dermatol. 2025 May 5 Epub 2025 May 05. View PubMed; Goyal A, O'Leary D, Dabaja B, Weng WK, Zain ...
In a phase 2 study, researchers will evaluate pembrolizumab as an initial therapy for patients with advanced mycosis fungoides. In a phase 2 study, researchers ...
... (Mycosis Fungoides) NCT ID: NCT02448381 POC ID: CLS-20491218. Pagination Clinical Studies. Go to page 11 · Go to page 22 · Go to page 33 · Go to page 44 · Go to ...
... mycosis fungoides (MF) or Sézary syndrome (SS) Forms of Cutaneous T-cell Lymphoma (CTCL). This study will also determine if there is systemic absorption of ...
... Mycosis fungoides. Show more areas of focus for Khaled Aziz, M.D., Ph.D. Sanjay P. Bagaria, M.D.. Surgical Oncologist. Jacksonville, FL ...
... Mycosis fungoides, Peripheral T-cell lymphoma. Show more areas of focus for Aaron R. Mangold, M.D.. Amir B. Orandi, M.D.. Pediatric ...
Participant has proven or probable IPA according to the modified 2019 European Organization for Research and Treatment of Cancer/ Mycoses Study Group ...
Learn about the symptoms, causes, treatments of this common skin infection that usually responds to treatment.
... Mycosis fungoides. Show more areas of focus for Khaled Aziz, M.D., Ph.D. N. Nora Bennani, M.D.. Internist; Oncologist; Hematologist.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.